)
Edge1 May 2026
Making the Marlboro Man
The story of Marlboro's transformation from a women's cigarette to a global icon: one of the most effective brand repositionings in history.
Relmada Therapeutics
Relmada Therapeutics (RLMD) investor relations material
Relmada Therapeutics Proxy filing summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.Proxy filing summary17 Apr, 2026
Executive summary
Annual Meeting scheduled for May 27, 2026, to be held virtually for shareholder participation.
Shareholders are encouraged to review proxy materials and vote by May 26, 2026.
Voting matters and shareholder proposals
Election of two Class II directors for three-year terms expiring at the 2029 Annual Meeting.
Ratification of CBIZ CPAs P.C. as independent auditor for the fiscal year ending December 31, 2026.
Amendment to the 2021 Equity Incentive Plan to increase available shares by 3 million.
Amendment to Articles of Incorporation to increase authorized common stock from 150 million to 200 million shares.
Provision to address any other business that may arise at the meeting.
Board of directors and corporate governance
Nominees for Class II director positions are Charles J. Casamento and Sergio Traversa.
Partial view of Summaries dataset, powered by Quartr API
AI can get things wrong. Verify important information.Research faster. Power your platform.
Latest events from Relmada Therapeutics
- NDV-01 delivers strong efficacy and safety in bladder cancer, with pivotal trials and funding secured.RLMD
Leerink Global Healthcare Conference 202630 Apr 2026 - A strategic pivot and successful financing in 2025 set the stage for renewed growth and shareholder value.RLMDProxy filing17 Apr 2026
- Shareholders will vote on key governance, compensation, and capital structure changes after a pivotal turnaround.RLMDProxy filing6 Apr 2026
- Biotech pivots pipeline, raises $160M, and registers 33.7M shares for investor resale.RLMDRegistration filing3 Apr 2026
- NDV-01 demonstrates high efficacy in NMIBC; Phase 3 trials and strong cash position support growth.RLMDCorporate presentation1 Apr 2026
- NDV-01 phase II shows 76% 12-month CR and $160M financing supports phase III launch.RLMDQ4 202520 Mar 2026
- NDV-01 delivers high response rates in NMIBC, with Phase 3 trials and strong financial runway ahead.RLMDCorporate presentation19 Mar 2026
- NDV-01 achieved durable, high response rates with favorable safety in high-risk NMIBC.RLMDStudy Result Presentation19 Mar 2026
- NDV-01 and sepranolone advance toward pivotal studies, supported by strong clinical and financial positions.RLMDInvestor presentation10 Mar 2026
Next Relmada Therapeutics earnings date
Q1 202611 May, 2026
Relmada Therapeutics
Next Relmada Therapeutics earnings date
Q1 202611 May, 2026
The essential earnings season companion
The #1 app for qualitative research. Live earnings calls, AI chat, transcripts, and more. All for free.
Live calls and transcripts
Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.
Find what you need faster
Search for any keyword across all transcripts simultaneously.
Easily store key findings
Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Your watchlist. Your dashboard.
Follow the companies that matter to you. Get a personalized feed with real-time updates.
Be the first to know
Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.
Consensus estimates
Access analyst consensus estimates, valuation multiples, and revenue segments splits.
All IR material in one place
The easiest way to stay updated during earnings season.
Global coverage
All events from public companies. Live and recorded.
Just click and listen
No webcast links. No manual registrations.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
)
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
)
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
I can't remember the last time an app had such a positive impact on my investment process.
)
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
I can't remember the last time an app had such a positive impact on my investment process.
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
)
)
Frequently asked questions
Explore our global coverage